Seminars in Oncology
Volume 31, Issue 6 , Pages 718-725 , December 2004

Head and neck cancer: The pursuit of molecular diagnostic markers

  • Rifat Hasina

      Affiliations

    • Departments of Pathology, Medicine, and Radiation and Cellular Oncology, The University of Chicago, Chicago, IL
    • ,
  • Mark W. Lingen

      Affiliations

    • Departments of Pathology, Medicine, and Radiation and Cellular Oncology, The University of Chicago, Chicago, IL
    • Corresponding Author InformationAddress reprint requests to Mark W. Lingen, DDS, PhD, Departments of Pathology, Medicine, and Radiation and Cellular Oncology, The University of Chicago, 5841 S Maryland Ave, Chicago, IL 60637

References 

  1. Vokes EE , Weichselbaum RR , Lippman SM , et al.   Head and neck cancer . N Engl J Med . 1993;328:184–194
  2. Forastiere A , Koch W , Trotti A , et al.   Head and neck cancer . N Engl J Med . 2001;345:1890–1900
  3. Pisani P , Bray F , Parkin DM . Estimates of the world-wide prevalence of cancer for 25 sites in the adult population . Int J Cancer . 2002;97:72–81
  4. Fearon ER , Volgelstein B . A genetic model for colorectal tumorigenesis . Cell . 1990;61:759–767
  5. Mao L , Lee JS , Fan YH , et al.   Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment . Nat Med . 1996;2:682–685
  6. Reed AL , Califano J , Cairns P , et al.   High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma . Cancer Res . 1996;56:3630–3633
  7. Papadimitrakopoulou V , Izzo J , Lippman SM , et al.   Frequent inactivation of p16INK4a in oral premalignant lesions . Oncogene . 1997;14:1799–1803
  8. Okami K , Reed AL , Cairns P , et al.   Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma . Oncogene . 1999;18:3541–3545
  9. Maestro R , Gasparotto D , Vukosavljevic T , et al.   Three discrete regions of deletion at 3p in head and neck cancers . Cancer Res . 1993;53:5775–5779
  10. Boyle JO , Hakim J , Koch W , et al.   The incidence of p53 mutations increases with progression of head and neck cancer . Cancer Res . 1993;53:4477–4480
  11. Rosin MP , Cheng X , Poh C , et al.   Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia . Clin Cancer Res . 2000;6:357–362
  12. Izzo JG , Papadimitrakopoulou VA , Li XQ , et al.   Dysregulated cyclin D1 expression early in head and neck tumorigenesis (In vivo evidence for an association with subsequent gene amplification) . Oncogene . 1998;17:2313–2322
  13. Capaccio P , Pruneri G , Carboni N , et al.   Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes . Head Neck . 2000;22:234–240
  14. Michalides R , van Veelen N , Hart A , et al.   Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck . Cancer Res . 1995;55:975–978
  15. Chang SE , Bhatia P , Johnson NW , et al.   ras mutations in United Kingdom examples of oral malignancies are infrequent . Int J Cancer . 1991;48:409–412
  16. Yeudall WA , Torrance LK , Elsegood KA , et al.   ras pont mutation is a rare event in premalignant tissue and malignant cells and tissues from oral mucosal lesions . Eur J Cancer Oral Oncol . 1993;29B:63–67
  17. Das N , Majumder J , DasGupta UB . ras gene mutations in oral cancer in eastern India . Oral Oncol . 2000;36:76–80
  18. Saranath D , Chang SE , Bhoite LT , et al.   High frequency mutations in codons 12 and 61 of H-ras oncogene in chewing tobacco related human oral squamous carcinoma in India . Br J Cancer . 1991;63:573–578
  19. Haraf DJ , Nodzenski E , Brachman D , et al.   Human papilloma virus and p53 in head and neck cancer (Clinical correlates and survival) . Clin Cancer Res . 1996;2:755–762
  20. Portugal LG , Goldenberg JD , Wenig BL , et al.   Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma . Arch Otolaryngol Head Neck Surg . 1997;123:1230–1234
  21. Penhallow J , Steingrimsdottir H , Elamin F , et al.   p53 alterations and HPV infections are common in oral SCC (p53 gene mutations correlate with the absence of HPV 16-E6 DNA) . Int J Oncol . 1998;12:59–68
  22. Gillison ML , Koch WM , Capone RB , et al.   Evidence for a causal association between human papillomavirus and a subset of head and neck cancers . J Natl Cancer Inst . 2000;92:709–720
  23. Wiest T , Schwarz E , Enders C , et al.   Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control . Oncogene . 2002;21:1510–1517
  24. Koch WM , Lango M , Sewell D , et al.   Head and neck cancer in nonsmokers (A distinct clinical and molecular entity) . Laryngoscope . 1999;109:1544–1551
  25. Lingen MW , Sturgis EM , Kies MS . Squamous cancer of the head and neck in non-smokers (Clinical and biological characteristics, and implications for therapy) . Curr Opin Oncol . 2001;13:176–182
  26. Schantz SP , Yu GP . Head and neck cancer incidence trends in young Americans, 1973–1997, with a special analysis for tongue cancer . Arch Otolaryngol Head Neck Surg . 2002;128:268–274
  27. Lingen MW , Chang K-W , Pelzer HJ , et al.   Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5–9 . Head Neck . 2000;22:328–335
  28. Wu X , Lippman SM , Lee JJ , et al.   Chromosome instability in lymphocytes (A potential indicator of predisposition to oral premalignant lesions) . Cancer Res . 2002;62:2813–2818
  29. Yu KK , Zanation AM , Moss JR , et al.   Familial head and neck cancer (Molecular analysis of a new clinical entity) . Laryngoscope . 2002;112:1587–1593
  30. Sturgis EM , Wei Q , et al.   Genetic susceptibility—Molecular epidemiology of head and neck cancer . Curr Opin Oncol . 2002;14:310–317
  31. Egeli U , Ozkan L , Tunca B , et al.   The relationship between genetic susceptibility to head and neck cancer with the expression of common fragile sites . Head Neck . 2000;22:591–598
  32. Leethanakul C , Patel V , Gillespie J , et al.   Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays . Oncogene . 2000;19:3220–3224
  33. Alevizos I , Mahadevappa M , Zhang X , et al.   Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis . Oncogene . 2001;20:6196–6204
  34. El-Naggar AK , Kim HW , Clayman GL , et al.   Differential expression profiling of head and neck squamous carcinoma (Significance in their phenotypic and biological classification) . Oncogene . 2002;21:8206–8219
  35. Belbin TJ , Singh B , Barber I , et al.   Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays . Cancer Res . 2002;62:1184–1190
  36. Mendez E , Cheng C , Farwell DG , et al.   Transcriptional expression profiles of oral squamous cell carcinomas . Cancer . 2002;95:1482–1494
  37. Ha PK , Benoit NE , Yochem R , et al.   A transcriptional progression model for head and neck cancer . Clin Cancer Res . 2003;9:3058–3064
  38. Yanagisawa K , Shyr Y , Xu BJ , et al.   Proteomic patterns of tumour subsets in non-small-cell lung cancer . Lancet . 2003;362:433–439
  39. Dwek MV , Alaiya AA . Proteome analysis enables separate clustering of normal breast, benign breast and breast cancer tissues . Br J Cancer . 2003;89:305–307
  40. Wulfkuhle JD , Liotta LA , Petricoin EF . Proteomic applications for the early detection of cancer. Nature reviews . Cancer . 2003;3:267–275
  41. Adam GC , Sorensen EJ , Cravatt BF . Proteomic profiling of mechanistically distinct enzyme classes using a common chemotype . Nat Biotechnol . 2002;20:805–809
  42. Wulfkuhle JD , Sgroi DC , Krutzsch H , et al.   Proteomics of human breast ductal carcinoma in situ . Cancer Res . 2002;62:6740–6749
  43. Melle C , Ernst G , Schimmel B , et al.   Biomarker discovery and identification in laser microdissected head and neck squamous cell carcinoma with ProteinChip(R) technology, two-dimensional gel electrophoresis, tandem mass spectrometry, and immunohistochemistry . Mol Cell Proteomics . 2003;2:443–452
  44. Silverman S . Early diagnosis of oral cancer . Cancer . 1988;62:1796–1799
  45. Shugars DC , Patton LL . Detecting, diagnosing, and preventing oral cancer . Nurse Pract . 1997;22:109–115
  46. Whited JD , Grichnick JM . Does this patient have a mole or a melanoma? . JAMA . 1998;279:696–701
  47. Rampen FH , Casparie-van Velsen JI , van Huystee BE , et al.   False-negative findings in skin cancer and melanoma screening . J Am Acad Dermatol . 1995;33:59–63
  48. Mashberg A , Feldman LJ . Clinical criteria for identifying early oral and oropharyngeal carcinoma (Erythroplasia revisted) . Am J Surg . 1988;156:273–275
  49. Sandler H . Cytological screening for early mouth cancer . Cancer . 1962;15:1119–1124
  50. Anneroth G , Batsakis J , Luna M . Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas . Scand J Dent Res . 1987;95:229–249
  51. Abbey LM , Kaugars GE , Gunsolley JC , et al.   Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia . Oral Surg Oral Med Oral Path Oral Radiat Endod . 1995;80:188–191
  52. De Vet HC , Koudstaal J , Kwee WS , et al.   Efforts to improve interobserver agreement in histopathological grading . J Clin Epidemiol . 1995;48:869–873
  53. Karabulut A , Reibel J , Therkildsen MH , et al.   Observer variability in the histologic assessment of oral premalignant lesions . J Oral Pathol Med . 1995;24:198–200
  54. Polverini PJ , Solt DB . Expression of the angiogenic phenotype by a subpopulation of keratinocytes from 7,12-dimethylbenz(a)anthracene-initiated hamster pouch epithelium . Carcinogenesis . 1988;9:117–122
  55. Morocco JR , Solt DB , Polverini PJ . Sequential loss of tumor suppressor genes for three specific functions during in vivo carcinogenesis . Lab Invest . 1990;63:298–306
  56. Lingen MW , DiPietro LA , Solt DB , et al.   H-ras stimulates anchorage independence but not TGFβ mediated angiogenesis in keratinocytes cultured from the in vivo hamster buccal pouch model of oral carcinogenesis . Carcinogenesis . 1997;18:329–338
  57. Sudbo J , Ried T , Bryne M , et al.   Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patches . Oral Oncol . 2001;37:558–565
  58. Lee JJ , Hong WK , Hittelman WN , et al.   Predicting cancer development in oral leukoplakia (Ten years of translational research) . Clin Cancer Res . 2000;6:1702–1710
  59. Guo Z , Yamaguchi K , Sanchez-Cespedes M , et al.   Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy . Clin Cancer Res . 2001;7:1963–1968
  60. Lee JS , Kim SY , Hong WK , et al.   Detection of chromosomal polysomy in oral leukoplakia, a premalignant lesion . J Natl Cancer Inst . 1993;85:1951–1954
  61. Mincer HH , Coleman SA , Hopkins KP . Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia . Oral Surg . 1972;33:389–399
  62. Evenson JW . Oral remalignancy . Cancer Surv . 1983;2:403–424
  63. Sudbo J , Kildal W , Risberg B , et al.   DNA content as a prognostic marker in patients with oral leukoplakia . N Engl J Med . 2001;344:1270–1278
  64. Sudbo J , Kildal W , Johannessen AC , et al.   Gross genomic aberrations in precancers (Clinical implications of a long-term follow-up study in oral erythroplakias) . J Clin Oncol . 2002;20:456–462
  65. Brennan JA , Mao L , Hruban RH , et al.   Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck . N Engl J Med . 1995;332:429–435
  66. Ahrendt SA , Hu Y , Buta M , et al.   p53 mutations and survival in stage I non-small-cell lung cancer (Results of a prospective study) . J Natl Cancer Inst . 2003;95:961–970
  67. Wikman FP , Lu ML , Thykjaer T , et al.   Evaluation of the performance of a p53 sequencing microarray chip using 140 previously sequenced bladder tumor samples . Clin Chem . 2000;46:1555–1561
  68. Wen WH , Bernstein L , Lescallett J , et al.   Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis . Cancer Res . 2000;60:2716–2722
  69. Ahrendt SA , Halachmi S , Chow JT , et al.   Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array . Proc Natl Acad Sci U S A . 1999;96:7382–7387
  70. Nathan CA , Amirghahri N , Rice C , et al.   Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients . Laryngoscope . 2002;112:2129–2140
  71. Zhang L , Poh CF , Lam WL , et al.   Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia (Molecular evidence of incomplete resection) . Oral Oncol . 2001;37:505–512
  72. Partridge M , Li SR , Pateromichelakis S , et al.   Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment . Clin Cancer Res . 2000;6:2718–2725
  73. Califano J , Westra WH , Koch W , et al.   Unknown primary head and neck squamous cell carcinoma (Molecular identification of the site of origin) . J Natl Cancer Inst . 1999;91:599–604
  74. Nieuwenhuis EJ , Leemans CR , Kummer A , et al.   Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription-polymerase chain reaction . Lab Invest . 2003;83:1233–1240
  75. Nieuwenhuis EJ , Jaspars LH , Castelijns JA , et al.   Institution quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates . Clin Cancer Res . 2003;9:755–761
  76. Koch WM , Brennan JA , Zahurak M , et al.   p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma . J Natl Cancer Inst . 1996;88:1580–1586
  77. Bradford CR , Zhu S , Ogawa H , et al.   p53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines . Head Neck . 2003;25:654–661
  78. Bergamaschi D , Gasco M , Hiller L , et al.   p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis . Cancer Cell . 2003;3:387–402
  79. Hasina R , Hulett K , Bicciato S , et al.   Plasminogen activator inhibitor-2 (A molecular biomarker for head and neck cancer progression) . Cancer Res . 2003;63:555–559
  80. Spafford MF , Koch WM , Reed AL , et al.   Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis . Clin Cancer Res . 2001;7:607–612
  81. Nawroz H , Koch W , Anker P , et al.   Microsatellite alterations in serum DNA of head and neck cancer patients . Nat Med . 1996;2:1035–1037

 Supported in part by National Institutes of Health Grants No. DE12322 and DE00470 (M.W.L.).

PII: S0093-7754(04)00409-9

doi: 10.1053/j.seminoncol.2004.09.012

Seminars in Oncology
Volume 31, Issue 6 , Pages 718-725 , December 2004

Article Tools

* Image Usage & Resolution